These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15582292)

  • 21. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
    Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.
    Romagosa C; Simonetti S; López-Vicente L; Mazo A; Lleonart ME; Castellvi J; Ramon y Cajal S
    Oncogene; 2011 May; 30(18):2087-97. PubMed ID: 21297668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3.
    Miki J; Fujimura Y; Koseki H; Kamijo T
    Genes Cells; 2007 Dec; 12(12):1371-82. PubMed ID: 18076574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
    Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P; Agarwal P; Bird RC
    J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16 and ARF: activation of teenage proteins in old age.
    Satyanarayana A; Rudolph KL
    J Clin Invest; 2004 Nov; 114(9):1237-40. PubMed ID: 15520854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The INK4a/ARF network in tumour suppression.
    Sherr CJ
    Nat Rev Mol Cell Biol; 2001 Oct; 2(10):731-7. PubMed ID: 11584300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency.
    Menendez S; Camus S; Herreria A; Paramonov I; Morera LB; Collado M; Pekarik V; Maceda I; Edel M; Consiglio A; Sanchez A; Li H; Serrano M; Belmonte JC
    Aging Cell; 2012 Feb; 11(1):41-50. PubMed ID: 21981310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.
    Carnero A; Hudson JD; Price CM; Beach DH
    Nat Cell Biol; 2000 Mar; 2(3):148-55. PubMed ID: 10707085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid asymmetric evolution of a dual-coding tumor suppressor INK4a/ARF locus contradicts its function.
    Szklarczyk R; Heringa J; Pond SK; Nekrutenko A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12807-12. PubMed ID: 17652172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the INK4a/Arf gene locus in senescence.
    Collins CJ; Sedivy JM
    Aging Cell; 2003 Jun; 2(3):145-50. PubMed ID: 12882406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ink4a/Arf expression is a biomarker of aging.
    Krishnamurthy J; Torrice C; Ramsey MR; Kovalev GI; Al-Regaiey K; Su L; Sharpless NE
    J Clin Invest; 2004 Nov; 114(9):1299-307. PubMed ID: 15520862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression of the p16(INK4a)-Rb and p19(Arf)-p53-p21(Cip/Waf1) signaling pathways in the regulation of hematopoietic stem cell aging by ginsenoside Rg1.
    Yue Z; Rong J; Ping W; Bing Y; Xin Y; Feng LD; Yaping W
    Genet Mol Res; 2014 Dec; 13(4):10086-96. PubMed ID: 25501220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.